Clinical Commissioning Policy Statement: Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

Document first published:
Page updated:
Topic:
Publication type:

Stereotactic ablative body radiotherapy (SABR) is recommended to be available as a treatment option through routine commissioning for adults with locally advanced, inoperable, non- metastatic pancreatic carcinoma (LANPC) within the criteria set out in this document.

Document

Clinical Commissioning Policy Statement: Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

Clinical Commissioning Policy Statement: Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

  • PDF
  • 304 KB
  • 12 pages

Document

Engagement report: Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

Engagement report: Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

  • PDF
  • 72 KB
  • 4 pages

Document

CPAG summary report: Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

CPAG summary report: Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

  • PDF
  • 91 KB
  • 7 pages

Document

Equality and Health Inequalities Impact Assessment (EHIA): Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

Equality and Health Inequalities Impact Assessment (EHIA): Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

  • PDF
  • 112 KB
  • 16 pages

Document

Clinical panel report: Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

Clinical panel report: Stereotactic ablative body radiotherapy for patients with locally advanced, inoperable, non-metastatic pancreatic carcinoma

  • PDF
  • 48 KB
  • 3 pages